[Multiple sclerosis and antiphospholipid syndrome--difficulties in differential diagnostics].

Area of Science:

• Autoimmune disorders
• Immunology
• Rheumatology

Context:

• Antiphospholipid syndrome (APS), or Hughes syndrome, is characterized by autoantibodies targeting phospholipids and associated proteins.
• Clinical manifestations include thrombotic events (venous and arterial) and recurrent pregnancy loss in women.
• Neurological symptoms are frequent and can present similarly to multiple sclerosis (MS).

Purpose:

• To highlight the importance of considering antiphospholipid antibodies in the differential diagnosis of neurological disorders.
• To emphasize the diagnostic challenge posed by neurological symptoms in APS that mimic multiple sclerosis.
• To advocate for the inclusion of APS in the diagnostic workup for patients with atypical neurological presentations.

Summary:

• APS involves autoantibody production leading to thrombosis and pregnancy complications.
• Neurological manifestations of APS can be mistaken for multiple sclerosis.
• Testing for antiphospholipid antibodies is crucial for diagnosing APS, especially in cases with neurological involvement.

Impact:

• Improved diagnostic accuracy for patients presenting with neurological symptoms suggestive of multiple sclerosis.
• Timely diagnosis of APS can lead to earlier anticoagulation therapy, potentially preventing thrombotic events.
• Enhanced understanding of the neurological manifestations of APS, contributing to comprehensive patient management.